(Reuters) -The U.S. Food and Drug Administration approved Zevra Therapeutics’ drug for a rare and fatal genetic disorder, making it the first
Johnson Controls (NYSE:JCI) International plc (NYSE:JCI) executive vice president and chief financial officer, Marc Vandiepenbeeck, has sold a portion of
(Reuters) – Global investors scooped up equity funds in the week to Sept. 18, anticipating the Federal Reserve’s interest rate cut to
By Indradip Ghosh BENGALURU (Reuters) – The U.S. Federal Reserve will cut the federal funds rate by 25 basis points in both November
OTTAWA, Sept 20 (Reuters) – Bank of Canada Governor Tiff Macklem on Friday said adoption of artificial intelligence (AI) by businesses could
By Bharath Rajeswaran BENGALURU (Reuters) – India’s NSE Nifty 50 and S&P BSE Sensex are trailing only Wall Street’s Nasdaq and S&P 500
(Reuters) – Futures linked to Canada’s main stock index fell on Friday, mirroring its Wall Street peers as investors paused after markets
BEIJING (Reuters) – China Minsheng Bank has cut pay by up to 50% for its Beijing branch employees, two people with direct
(Reuters) – U.S. stock index futures edged lower on Friday, taking a pause from the previous session’s rally that set Wall Street’s
Investing.com — Barclays analysts are skeptical that the Federal Reserve will cut interest rates as aggressively as the market currently expects. In a
